Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 309,692 | 89,048 | 82,909 | 51,388 | 55,680 |
| Receivables | 1,140 | 503 | 413 | 273 | 234 |
| TOTAL | $312,293 | $90,788 | $84,310 | $52,369 | $56,315 |
| Non-Current Assets | |||||
| PPE Net | 72 | 92 | 112 | 129 | 155 |
| TOTAL | $72 | $92 | $112 | $129 | $155 |
| Total Assets | $312,365 | $90,880 | $84,422 | $52,498 | $56,469 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,630 | 1,431 | 1,710 | 511 | 551 |
| Accrued Expenses | 121 | 63 | 541 | 16 | 9 |
| TOTAL | $3,833 | $1,583 | $2,335 | $605 | $638 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $17 | $41 | $63 | $89 |
| Total Liabilities | $3,833 | $1,599 | $2,377 | $668 | $727 |
| Shareholders' Equity | |||||
| Common Shares | 365,779 | 136,772 | 123,250 | 89,910 | 89,895 |
| Retained earnings | -64,603 | -54,144 | -46,578 | -42,493 | -37,250 |
| Other shareholders' equity | 7,357 | 6,652 | 5,373 | 4,412 | 3,097 |
| TOTAL | $308,532 | $89,281 | $82,045 | $51,830 | $55,743 |
| Total Liabilities And Equity | $312,365 | $90,880 | $84,422 | $52,498 | $56,469 |